Cargando…
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
BACKGROUND: Global DNA methylation alterations are hallmarks of cancer. The tumor-suppressive TET enzymes, which are involved in DNA demethylation, are decreased in prostate cancer (PCa); in particular, TET2 is specifically targeted by androgen-dependent mechanisms of repression in PCa and may play...
Autores principales: | Kamdar, Shivani, Isserlin, Ruth, Van der Kwast, Theodorus, Zlotta, Alexandre R., Bader, Gary D., Fleshner, Neil E., Bapat, Bharati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438015/ https://www.ncbi.nlm.nih.gov/pubmed/30917865 http://dx.doi.org/10.1186/s13148-019-0651-z |
Ejemplares similares
-
Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis
por: Kamdar, Shivani N., et al.
Publicado: (2016) -
A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence
por: Kamdar, Shivani, et al.
Publicado: (2020) -
Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer
por: Peter, Madonna R., et al.
Publicado: (2021) -
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer()
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2017)